Zobrazeno 1 - 10
of 1 160
pro vyhledávání: '"R, Pelletier"'
Autor:
Edward L. Snyder, Michael E. Sekela, Ian J. Welsby, Yoshiya Toyoda, Mohamed Alsammak, Neel R. Sodha, Thomas M. Beaver, J. Peter R. Pelletier, James D. Gorham, John S. McNeil, Roman M. Sniecinski, Ronald G. Pearl, Gregory A. Nuttall, Ravi Sarode, T. Brett Reece, Alesia Kaplan, Robertson D. Davenport, Tina S. Ipe, Peyman Benharash, Ileana Lopez-Plaza, Richard R. Gammon, Patrick Sadler, John P. Pitman, Kathy Liu, Stanley Bentow, Laurence Corash, Nina Mufti, Jeanne Varrone, Richard J. Benjamin, for the ReCePI study group
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-13 (2023)
Abstract Background Red blood cell (RBC) transfusion is a critical supportive therapy in cardiovascular surgery (CVS). Donor selection and testing have reduced the risk of transfusion-transmitted infections; however, risks remain from bacteria, emerg
Externí odkaz:
https://doaj.org/article/6afcdc33fc664ea1b6806a81a0f891ba
Autor:
Rohan Diwanji, Neil A. O'Brien, Jiyoung E. Choi, Beverly Nguyen, Tyler Laszewski, Angelo L. Grauel, Zheng Yan, Xin Xu, Jincheng Wu, David A. Ruddy, Michelle Piquet, Marc R. Pelletier, Alexander Savchenko, LaSalette Charette, Vanessa Rodrik-Outmezguine, Jason Baum, John M. Millholland, Connie C. Wong, Anne-Marie Martin, Glenn Dranoff, Iulian Pruteanu-Malinici, Viviana Cremasco, Catherine Sabatos-Peyton, Pushpa Jayaraman
Publikováno v:
Cancer Immunology Research. :OF1-OF15
High levels of IL1β can result in chronic inflammation, which in turn can promote tumor growth and metastasis. Inhibition of IL1β could therefore be a promising therapeutic option in the treatment of cancer. Here, the effects of IL1β blockade indu
Publikováno v:
Journal for Nurses in Professional Development. 39:44-50
Autor:
Jackson A. Killian, Taha M. Topiwala, Alex R. Pelletier, David E. Frankhouser, Pearlly S. Yan, Ralf Bundschuh
Publikováno v:
BMC Genomics, Vol 19, Iss 1, Pp 1-16 (2018)
Abstract Background Gene fusions often occur in cancer cells and in some cases are the main driver of oncogenesis. Correct identification of oncogenic gene fusions thus has implications for targeted cancer therapy. Recognition of this potential has l
Externí odkaz:
https://doaj.org/article/51f7aa11f5a0449da052784b5c99f0c2
Publikováno v:
IEEE Robotics and Automation Letters. 7:10208-10215
Autor:
Pushpa Jayaraman, Catherine Sabatos-Peyton, Viviana Cremasco, Iulian Pruteanu-Malinici, Glenn Dranoff, Anne-Marie Martin, Connie C. Wong, John M. Millholland, Jason Baum, Vanessa Rodrik-Outmezguine, LaSalette Charette, Alexander Savchenko, Marc R. Pelletier, Michelle Piquet, David A. Ruddy, Jincheng Wu, Xin Xu, Zheng Yan, Angelo L. Grauel, Tyler Laszewski, Beverly Nguyen, Jiyoung E. Choi, Neil A. O'Brien, Rohan Diwanji
Supplementary tables S1-S5 and figures S1-S7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a762d6444e9a4cf2897afec74d3f1d1
https://doi.org/10.1158/2326-6066.22812251
https://doi.org/10.1158/2326-6066.22812251
Autor:
Pushpa Jayaraman, Catherine Sabatos-Peyton, Viviana Cremasco, Iulian Pruteanu-Malinici, Glenn Dranoff, Anne-Marie Martin, Connie C. Wong, John M. Millholland, Jason Baum, Vanessa Rodrik-Outmezguine, LaSalette Charette, Alexander Savchenko, Marc R. Pelletier, Michelle Piquet, David A. Ruddy, Jincheng Wu, Xin Xu, Zheng Yan, Angelo L. Grauel, Tyler Laszewski, Beverly Nguyen, Jiyoung E. Choi, Neil A. O'Brien, Rohan Diwanji
High levels of IL1β can result in chronic inflammation, which in turn can promote tumor growth and metastasis. Inhibition of IL1β could therefore be a promising therapeutic option in the treatment of cancer. Here, the effects of IL1β blockade indu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b3380997b9e0f7a82acb06dfc9d926a
https://doi.org/10.1158/2326-6066.c.6644591
https://doi.org/10.1158/2326-6066.c.6644591
Autor:
Salvatore Siena, Vasileios Askoxylakis, Glenn Dranoff, Marc R. Pelletier, Lang Ho Lee, Lori A. Iaconis, Sarah M. Choi, Heidi A. Schoenfeld, Kulandayan Subramanian, Ping C. Mahling, Susan E. Cellitti, Alex Cortez, Yasutoshi Kuboki, Jaffer A. Ajani, Alessio Amatu, Toshihiko Doi, Sae-Won Han, Filip Janku
Immune-stimulator antibody conjugates (ISAC) combining tumor-targeting monoclonal antibodies with immunostimulatory agents allow targeted delivery of immune activators into tumors. NJH395 is a novel, first-in-class ISAC comprising a Toll‐like recep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7971b7d07116fc0c53b6de7673a36ee9
https://doi.org/10.1158/2326-6066.c.6551021.v1
https://doi.org/10.1158/2326-6066.c.6551021.v1
Autor:
Salvatore Siena, Vasileios Askoxylakis, Glenn Dranoff, Marc R. Pelletier, Lang Ho Lee, Lori A. Iaconis, Sarah M. Choi, Heidi A. Schoenfeld, Kulandayan Subramanian, Ping C. Mahling, Susan E. Cellitti, Alex Cortez, Yasutoshi Kuboki, Jaffer A. Ajani, Alessio Amatu, Toshihiko Doi, Sae-Won Han, Filip Janku
Supplementary Figure from Preclinical Characterization and Phase I Study of an Anti–HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::704176b41c46a7157ecea1d47d7de480
https://doi.org/10.1158/2326-6066.22545746.v1
https://doi.org/10.1158/2326-6066.22545746.v1
Autor:
Salvatore Siena, Vasileios Askoxylakis, Glenn Dranoff, Marc R. Pelletier, Lang Ho Lee, Lori A. Iaconis, Sarah M. Choi, Heidi A. Schoenfeld, Kulandayan Subramanian, Ping C. Mahling, Susan E. Cellitti, Alex Cortez, Yasutoshi Kuboki, Jaffer A. Ajani, Alessio Amatu, Toshihiko Doi, Sae-Won Han, Filip Janku
Supplementary Data from Preclinical Characterization and Phase I Study of an Anti–HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a5f94745c1462cb05163a0a0fdf5af8
https://doi.org/10.1158/2326-6066.22545749.v1
https://doi.org/10.1158/2326-6066.22545749.v1